These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24033789)

  • 1. Shaping and remodeling of the fetoplacental circulation: aspects of health and disease.
    Haas TL
    Microcirculation; 2014 Jan; 21(1):1-3. PubMed ID: 24033789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex expression changes of the placental endothelin system in early and late onset preeclampsia, fetal growth restriction and gestational diabetes.
    Dieber-Rotheneder M; Beganovic S; Desoye G; Lang U; Cervar-Zivkovic M
    Life Sci; 2012 Oct; 91(13-14):710-5. PubMed ID: 22580289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphometric evidence that villous development and fetoplacental angiogenesis are compromised by intrauterine growth restriction but not by pre-eclampsia.
    Mayhew TM; Wijesekara J; Baker PN; Ong SS
    Placenta; 2004 Nov; 25(10):829-33. PubMed ID: 15451198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia.
    Kaufmann P; Black S; Huppertz B
    Biol Reprod; 2003 Jul; 69(1):1-7. PubMed ID: 12620937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The feto-placental endothelium in pregnancy pathologies.
    Wadsack C; Desoye G; Hiden U
    Wien Med Wochenschr; 2012 May; 162(9-10):220-4. PubMed ID: 22717877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive mediator release by fetal endothelial cells in intrauterine growth restriction and preeclampsia.
    Parra MC; Lees C; Mann GE; Pearson JD; Nicolaides KH
    Am J Obstet Gynecol; 2001 Feb; 184(3):497-502. PubMed ID: 11228509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction.
    Kovo M; Schreiber L; Ben-Haroush A; Gold E; Golan A; Bar J
    Prenat Diagn; 2012 Jul; 32(7):632-7. PubMed ID: 22565848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fetoplacental disturbances in gestational diabetes mellitus].
    Hiden U; Lang U; Desoye G
    Gynakol Geburtshilfliche Rundsch; 2009; 49(4):224-9. PubMed ID: 20530933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal uterine vascular remodeling during pregnancy.
    Osol G; Moore LG
    Microcirculation; 2014 Jan; 21(1):38-47. PubMed ID: 23941526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human placental bed revisited.
    Lyall F
    Placenta; 2002; 23(8-9):555-62. PubMed ID: 12361674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial progenitor cells in pregnancy.
    Robb AO; Mills NL; Newby DE; Denison FC
    Reproduction; 2007 Jan; 133(1):1-9. PubMed ID: 17244727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myometrial and placental artery reactivity alone cannot explain reduced placental perfusion in pre-eclampsia and intrauterine growth restriction.
    Ong SS; Moore RJ; Warren AY; Crocker IP; Fulford J; Tyler DJ; Gowland PA; Baker PN
    BJOG; 2003 Oct; 110(10):909-15. PubMed ID: 14550360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent trophoblast invasion and apoptosis in placental bed spiral arteries from pregnancies complicated by maternal anemia and early-onset preeclampsia/intrauterine growth restriction.
    Kadyrov M; Kingdom JC; Huppertz B
    Am J Obstet Gynecol; 2006 Feb; 194(2):557-63. PubMed ID: 16458661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTX3 as a potential endothelial dysfunction biomarker for severity of preeclampsia and IUGR.
    Cozzi V; Garlanda C; Nebuloni M; Maina V; Martinelli A; Calabrese S; Cetin I
    Placenta; 2012 Dec; 33(12):1039-44. PubMed ID: 23062219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human physiological adaptation to pregnancy: inter- and intraspecific perspectives.
    Rockwell LC; Vargas E; Moore LG
    Am J Hum Biol; 2003; 15(3):330-41. PubMed ID: 12704709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the role of LC-PUFA metabolism in pregnancy complications.
    Godhamgaonkar AA; Wadhwani NS; Joshi SR
    Prostaglandins Leukot Essent Fatty Acids; 2020 Dec; 163():102203. PubMed ID: 33227645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia.
    Brownbill P; Mills TA; Soydemir DF; Sibley CP
    Placenta; 2008 Nov; 29(11):950-5. PubMed ID: 18845336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental vascular pathology as a mechanism of disease in pregnancy complications.
    Kovo M; Schreiber L; Bar J
    Thromb Res; 2013 Jan; 131 Suppl 1():S18-21. PubMed ID: 23452733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factors in preeclampsia: a vascular disease model. A failed vasodilation and angiogenic challenge from pregnancy onwards?
    Conti E; Zezza L; Ralli E; Caserta D; Musumeci MB; Moscarini M; Autore C; Volpe M
    Cytokine Growth Factor Rev; 2013 Oct; 24(5):411-25. PubMed ID: 23800655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of placental growth hormone in the alteration of maternal arterial resistance in pregnancy.
    Schiessl B; Strasburger CJ; Bidlingmaier M; Gutt B; Kirk SE; Oberhoffer R; Friese K
    J Reprod Med; 2007 Apr; 52(4):313-6. PubMed ID: 17506372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.